BRONCHIAL ATRESIA

This adverse event was reported 7 times

These drugs are most commonly taken by patients reporting BRONCHIAL ATRESIA:

# Drug Count
0 ANAKINRA 5
1 CANAKINUMAB 5
2 METHOTREXATE SODIUM 5
3 METHYLPREDNISOLONE 5
4 PREDNISOLONE 5
5 PREDNISOLONE ORAL 5
6 PREDNISOLONE ORAL SOLUTION 5
7 PREDNISONE 5
8 RUXOLITINIB 5
9 TACROLIMUS 5
See all common drugs associated with BRONCHIAL ATRESIA

BRONCHIAL ATRESIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PENTAMIDINE ISETHIONATE 1 0.0008
1 CANAKINUMAB 5 0.0005
2 TOFACITINIB CITRATE 5 0.0004
3 ATOVAQUONE 3 0.0004
4 ANAKINRA 5 0.0003
5 RUXOLITINIB 5 0.0001
6 TACROLIMUS OINTMENT 0.1% 5 0.0000
7 TACROLIMUS EXTENDED-RELEASE CAPSULES 5 0.0000
8 METHYLPREDNISOLONE 5 0.0000
9 TACROLIMUS 5 0.0000
See all drugs enriched for association with BRONCHIAL ATRESIA

BRONCHIAL ATRESIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 5 0.0003
1 Antimalarial [EPC] 3 0.0003
2 Antiprotozoal [EPC] 3 0.0003
3 Janus Kinase Inhibitor [EPC] 5 0.0000
4 Interleukin-6 Receptor Antagonist [EPC] 3 0.0000
5 Kinase Inhibitor [EPC] 5 0.0000
6 Corticosteroid [EPC] 5 0.0000
See all drug classes enriched for association with BRONCHIAL ATRESIA